FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4321595993> ?p ?o ?g. }

• W4321595993 abstract "Background: Alzheimer’s disease (AD), a chronic neurodegenerative disorder predominantly occurs among the elderly, is the leading cause of dementia. The accumulation of β-amyloid (Aβ) is considered the main pathogenies of AD, and β-site APP-cleaving enzyme 1 (BACE1) plays an important role in the formulation of Aβ. background: Alzheimer’s disease (AD), a chronic neurodegenerative disorder predominantly occurs among the elderly, is the leading cause of dementia. The accumulation of β-amyloid (Aβ) is considered as the main pathogenies of AD, and β-site APP-cleaving enzyme 1 (BACE1) plays an important role in the formulation of Aβ. Objective: In order to find a new scaffold as BACE1 inhibitors, a series of novel 2-amino-1-phenyl-benzimidazole derivatives were designed and synthesized in this work. objective: In order to find new scaffold as BACE1 inhibitors, a series of novel 2-amino-1-phenyl-benzimidazole derivatives were designed and synthesized in this work. Methods: Using our previous L-5 as a lead compound, we applied a scaffold hopping method and merged 2-amino-1-methyl-4-phenyl-1H-imidazol-5 (4H)-one into benzimidazole, so a novel class of BACE1 inhibitors T1~T20 with the structure of 2-amino-1-phenyl-benzimidazole were designed and synthesized. Results: The biological activity evaluation indicated that the target compounds showed inhibitory activities against BACE1, with T14 being the most potent (IC50 = 0.45 μM), it also exhibited good logP value and tPSA. The docking studies indicated that compound T14 could form important hydrogen bonds with Asp289 and Asp93. Conclusion: Compound T14 could be used as a potential BACE1 inhibitor for further modification to treat AD. conclusion: Compound T14 could be used as potential BACE1 inhibitor for further modification to treat AD. other: No" @default.
• W4321595993 created "2023-02-24" @default.
• W4321595993 creator A5004157378 @default.
• W4321595993 creator A5004493351 @default.
• W4321595993 creator A5019766538 @default.
• W4321595993 creator A5022016074 @default.
• W4321595993 creator A5022930741 @default.
• W4321595993 creator A5026973079 @default.
• W4321595993 creator A5032657150 @default.
• W4321595993 creator A5035191050 @default.
• W4321595993 creator A5037607492 @default.
• W4321595993 creator A5047779834 @default.
• W4321595993 creator A5049334682 @default.
• W4321595993 creator A5055999528 @default.
• W4321595993 creator A5058640796 @default.
• W4321595993 creator A5060842660 @default.
• W4321595993 creator A5066028215 @default.
• W4321595993 creator A5078249865 @default.
• W4321595993 creator A5083828424 @default.
• W4321595993 creator A5084104467 @default.
• W4321595993 creator A5084531859 @default.
• W4321595993 creator A5087595168 @default.
• W4321595993 creator A5087602552 @default.
• W4321595993 creator A5091159380 @default.
• W4321595993 date "2023-02-23" @default.
• W4321595993 modified "2023-10-16" @default.
• W4321595993 title "Synthesis and Biological Evaluation of 2-Amino-1-phenyl-benzimidazole Derivatives as BACE1 Inhibitors" @default.
• W4321595993 doi "https://doi.org/10.2174/1570180820666230223151850" @default.
• W4321595993 hasPublicationYear "2023" @default.
• W4321595993 type Work @default.
• W4321595993 citedByCount "0" @default.
• W4321595993 crossrefType "journal-article" @default.
• W4321595993 hasAuthorship W4321595993A5004157378 @default.
• W4321595993 hasAuthorship W4321595993A5004493351 @default.
• W4321595993 hasAuthorship W4321595993A5019766538 @default.
• W4321595993 hasAuthorship W4321595993A5022016074 @default.
• W4321595993 hasAuthorship W4321595993A5022930741 @default.
• W4321595993 hasAuthorship W4321595993A5026973079 @default.
• W4321595993 hasAuthorship W4321595993A5032657150 @default.
• W4321595993 hasAuthorship W4321595993A5035191050 @default.
• W4321595993 hasAuthorship W4321595993A5037607492 @default.
• W4321595993 hasAuthorship W4321595993A5047779834 @default.
• W4321595993 hasAuthorship W4321595993A5049334682 @default.
• W4321595993 hasAuthorship W4321595993A5055999528 @default.
• W4321595993 hasAuthorship W4321595993A5058640796 @default.
• W4321595993 hasAuthorship W4321595993A5060842660 @default.
• W4321595993 hasAuthorship W4321595993A5066028215 @default.
• W4321595993 hasAuthorship W4321595993A5078249865 @default.
• W4321595993 hasAuthorship W4321595993A5083828424 @default.
• W4321595993 hasAuthorship W4321595993A5084104467 @default.
• W4321595993 hasAuthorship W4321595993A5084531859 @default.
• W4321595993 hasAuthorship W4321595993A5087595168 @default.
• W4321595993 hasAuthorship W4321595993A5087602552 @default.
• W4321595993 hasAuthorship W4321595993A5091159380 @default.
• W4321595993 hasConcept C112887158 @default.
• W4321595993 hasConcept C126322002 @default.
• W4321595993 hasConcept C15744967 @default.
• W4321595993 hasConcept C159110408 @default.
• W4321595993 hasConcept C169760540 @default.
• W4321595993 hasConcept C17077164 @default.
• W4321595993 hasConcept C178790620 @default.
• W4321595993 hasConcept C181199279 @default.
• W4321595993 hasConcept C185592680 @default.
• W4321595993 hasConcept C202751555 @default.
• W4321595993 hasConcept C21951064 @default.
• W4321595993 hasConcept C2777752112 @default.
• W4321595993 hasConcept C2777752497 @default.
• W4321595993 hasConcept C2778484023 @default.
• W4321595993 hasConcept C2779134260 @default.
• W4321595993 hasConcept C2779483572 @default.
• W4321595993 hasConcept C31705614 @default.
• W4321595993 hasConcept C32909587 @default.
• W4321595993 hasConcept C41685203 @default.
• W4321595993 hasConcept C502032728 @default.
• W4321595993 hasConcept C55493867 @default.
• W4321595993 hasConcept C71240020 @default.
• W4321595993 hasConcept C71924100 @default.
• W4321595993 hasConceptScore W4321595993C112887158 @default.
• W4321595993 hasConceptScore W4321595993C126322002 @default.
• W4321595993 hasConceptScore W4321595993C15744967 @default.
• W4321595993 hasConceptScore W4321595993C159110408 @default.
• W4321595993 hasConceptScore W4321595993C169760540 @default.
• W4321595993 hasConceptScore W4321595993C17077164 @default.
• W4321595993 hasConceptScore W4321595993C178790620 @default.
• W4321595993 hasConceptScore W4321595993C181199279 @default.
• W4321595993 hasConceptScore W4321595993C185592680 @default.
• W4321595993 hasConceptScore W4321595993C202751555 @default.
• W4321595993 hasConceptScore W4321595993C21951064 @default.
• W4321595993 hasConceptScore W4321595993C2777752112 @default.
• W4321595993 hasConceptScore W4321595993C2777752497 @default.
• W4321595993 hasConceptScore W4321595993C2778484023 @default.
• W4321595993 hasConceptScore W4321595993C2779134260 @default.
• W4321595993 hasConceptScore W4321595993C2779483572 @default.
• W4321595993 hasConceptScore W4321595993C31705614 @default.
• W4321595993 hasConceptScore W4321595993C32909587 @default.
• W4321595993 hasConceptScore W4321595993C41685203 @default.
• W4321595993 hasConceptScore W4321595993C502032728 @default.
• W4321595993 hasConceptScore W4321595993C55493867 @default.
• W4321595993 hasConceptScore W4321595993C71240020 @default.
• W4321595993 hasConceptScore W4321595993C71924100 @default.

• next